-
Rinvoq Shows Superior Remission Rates in Giant-Cell Arteritis With Reduced Steroid Use, Phase III Trial Finds
23 Apr 2025 17:18 GMT
… the only FDA-approved medication indicated for … treat moderate-to-severe rheumatoid arthritis; active psoriatic arthritis; active ankylosing spondylitis … to the trial investigators. The trial’s key … cumulative exposure than treatment with glucocorticoids alone …
-
Biologic Psoriasis Treatments May Have Lower Cardiovascular Disease Risk than Oral
23 Apr 2025 17:01 GMT
… modifying anti-rheumatic drugs had a substantially … such as rheumatoid arthritis, ankylosing spondylitis, juvenile idiopathic arthritis, … the oral cohort developed CVDs over the … dosage, duration, and treatment sequencing across biologic therapies …
-
Augurex Announces UKCA Authorization for SPINEstat™, Expanding Access to a First-in-Class Diagnostic Blood Test for Axial Spondyloarthritis to Great Britain
23 Apr 2025 06:37 GMT
… diagnosis of autoimmune disorders, allowing treatment options to be optimized and … a component of diagnostic tests developed by such laboratories. The Anti … diagnostic autoimmune solutions into axial spondyloarthritis, an autoimmune disease often misdiagnosed …
-
5 Rock-Solid Passive Income Dividend Aristocrats That Are Reasonably Safe From Tariffs
25 Apr 2025 11:18 GMT
… AbbVie discovers, develops, manufactures, and sells pharmaceuticals worldwide.
The company … disease
Rinvoq to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis … treatment of adult patients with blood cancers; Epkinly to treat …
-
Letter: Medicaid has been my lifeline
23 Apr 2025 20:43 GMT
… brother, who has bamboo spine (ankylosing spondylitis), causing him constant pain. Caretaking … nature; I was raised to treat people how I want to … be able to afford the medications that keep me going. Cutting …
-
Clinical studies with Jusvinza are being extended to other autoimmune and respiratory diseases
23 Apr 2025 17:05 GMT
… an alternative for the treatment of Cuban patients suffering … autoimmune diseases such as ankylosing spondylitis, systemic lupus erythematosus and … product is a therapeutic drug, not a preventive one … one is also being developed in severe community-acquired …
-
Celltrion Adalimumab Biosimilar Granted Interchangeability Designation
21 Apr 2025 21:23 GMT
… S. Food and Drug Administration granted an … product at the pharmacy without the intervention … is FDA approved for the treatment of … patients with rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis …
-
MoonLake Immunotherapeutics to host a Capital Markets Day on Tuesday, April 29
25 Apr 2025 20:05 GMT
… (PPP) and axial spondyloarthritis (axSpA). For adults … MIRA trial at 24 weeks showed that maintenance treatment … primary endpoint evaluating the pharmacokinetics, safety, and tolerability … trials and research and development programs; the anticipated …
-
Is MoonLake Immunotherapeutics (MLTX) Among the Best Guru Stocks to Buy According to Wall Street Analysts?
25 Apr 2025 04:44 GMT
… company focused on developing therapies for inflammatory diseases … Suppurativa, psoriatic arthritis, axial spondyloarthritis, and psoriasis. With … with its drug, Bimzelx, used to treat Hidradenitis Suppurativa, … respond well to TNF treatments. Early in 2025, …
-
Diversity Rises for Some but Not All in AxSpA Trials
24 Apr 2025 09:19 GMT
TOPLINE:
Axial spondyloarthritis (axSpA) clinical trials showed … 2, 3, and 4 drug trials for axSpA from … sex, race, ethnicity, trial characteristics, and trial locations were extracted and … of individuals enrolled in axSpA drug trials, significant gaps remain, …